01OverviewDefinition, clinical context and the essential points that orientate the chapter.
Necrotizing pancreatitis involves non-viable pancreatic tissue, peripancreatic tissue or both. It is a description of tissue injury, not a synonym for infection. During the early illness, pain, fever and inflammatory markers can arise from sterile inflammation, while organ failure needs support whatever its cause. Later deterioration may reflect infection of necrotic tissue, an unrelated infection or a mechanical or vascular complication. The treatment decision therefore rests on the changing clinical picture and a defined problem rather than the CT word necrosis alone.
Management combines physiology, nutrition, antimicrobial stewardship and anatomical source control. A stable patient may improve without intervention, and some infected collections respond to antibiotics alone. A patient with uncontrolled sepsis may need drainage before the conventional four-week point. Specialist teams choose the safest feasible route and reassess whether it has achieved adequate drainage before escalating to necrosectomy. The aim is control of the illness with the least necessary tissue disruption, while recognising situations that demand urgent intervention.
Key points
- Necrosis may remain sterile; neither its extent nor an isolated fever justifies prophylactic antibiotics.
- Suspect infected necrosis from the clinical course, sepsis features and imaging; gas or an appropriate positive culture strengthens the diagnosis.
- For suspected infection, give appropriate IV antibiotics and assess source control. Delay intervention while clinically safe; persistent sepsis may need earlier drainage, followed by debridement only if required.
- Routine fine-needle aspiration is unnecessary when the clinical and imaging evidence already supports the decision; a negative sample does not reliably exclude infection.
- If clinical stability allows, postpone intervention until the collection has demarcated, commonly around four weeks; earlier drainage may be necessary when treatment fails.
- Use a step-up strategy: antibiotics and support, drainage when indicated, then debridement only if the response or anatomy requires it.
02AetiologyUnderlying causes, associations and risk factors, with why each one matters.
Necrotizing tissue injury
Necrosis can complicate acute pancreatitis from several causes and may involve the gland, surrounding fat or both. Its development reflects the severity and distribution of injury; the presence of dead tissue does not prove bacterial infection.
Secondary infection
Necrotic tissue can become infected during the course of illness. Enteric organisms are relevant, but prior antimicrobials, hospital exposure and procedures influence the microbiology, so appropriate cultures and the local susceptibility pattern inform treatment.
03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.
- 1Loss of tissue viability
Pancreatic injury and impaired microcirculation can lead to non-viable tissue. Early collections contain variable proportions of fluid and necrotic material, making drainage and interpretation different from those of a simple fluid cavity.
- 2Inflammation and infection diverge
Sterile necrosis can sustain a substantial inflammatory response with fever and organ dysfunction. Secondary infection adds a source-control problem, but the clinical overlap means that inflammatory markers alone cannot reliably distinguish the two states.
- 3Demarcation over time
Necrotic collections commonly become more encapsulated and partly liquefied over several weeks. This maturation can aid safer drainage or debridement, while progressive sepsis may make earlier intervention necessary before a completely mature wall has developed.
04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.
A patient with necrosis who is improving clinically, without convincing infection evidence, usually needs supportive treatment and surveillance. Early fever, leucocytosis or a raised CRP does not convert sterile tissue injury into bacterial infection. Review respiratory, urinary, line-related and other possible sources if infection is suspected, rather than treating the pancreatic appearance as the only explanation.
Failure to improve or a new deterioration after the first week, especially with fever, sepsis or worsening organ function, raises concern for infected necrosis. Timing can support suspicion but is not an exclusion rule: infection can occur earlier. Assess the whole course, prior antibiotics, procedures and other sources before deciding which treatment is needed.
Persistent vomiting, inability to sustain nutrition, obstructive jaundice or prolonged pain may result from a necrotic collection even if it is sterile. These symptoms can become indications for intervention once their cause and anatomy are established. Persistent symptoms should not be treated simply by escalating analgesia without revisiting imaging and nutrition.
A sudden haemoglobin fall, haemodynamic instability, gastrointestinal bleeding or blood from an existing drain raises concern for vascular erosion or pseudoaneurysm. Peritonism or evidence of bowel ischaemia/perforation is another urgent pathway. These complications can require immediate interventional radiology or surgery; they do not wait for routine collection maturation.
05InvestigationsWhat to request, why it matters and how to interpret it.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Contrast-enhanced CT for the new clinical questionFirst step - Why
- Define necrosis, collection anatomy and a cause of deterioration.
- Interpretation and limitations
- Describe non-enhancing tissue, liquid and solid components, wall development, location, vessels and adjacent bowel. Gas within an untreated necrotic collection is strongly suggestive of infection, although bowel communication or previous instrumentation changes interpretation. Absence of gas does not exclude infection. Imaging should support an actionable decision and be repeated for a change in condition or intervention planning rather than on an automatic schedule.
- 02
Blood cultures and targeted infection assessment - Why
- Identify organisms and sources without delaying urgent treatment.
- Interpretation and limitations
- Obtain suitable cultures when feasible before antibiotics, but do not delay sepsis treatment to achieve that sequence. Assess lungs, urine, intravascular devices and other likely sources. Organisms from blood or a fresh drainage sample can guide narrowing or changing therapy; interpret colonisation of a long-standing drain cautiously rather than treating every isolate as invasive infection.
- 03
Inflammatory and organ-function trends - Why
- Judge the clinical trajectory and response to medical treatment.
- Interpretation and limitations
- CRP, white cells and procalcitonin can add evidence but cannot alone distinguish sterile inflammation from infection. Trend temperature, circulation, oxygen need, kidney function and nutritional delivery. Persistent sepsis despite active antibiotics is a reason to reassess source control, not simply to wait for a laboratory marker to fall.
- 04
Selective aspiration and drainage sampling - Why
- Obtain microbiology when it will alter management.
- Interpretation and limitations
- Routine diagnostic fine-needle aspiration is not recommended before treating suspected infected necrosis. False-negative results occur, and puncture can introduce infection. Sampling may be useful in an unresolved diagnostic problem or failure of treatment, especially with concern for resistant or fungal infection. When drainage is performed, send appropriate fresh samples and use the result with the clinical response.
06Differential diagnosisRealistic alternatives and the features that help distinguish them.
Sterile systemic inflammation
Early sterile pancreatic injury can produce fever, leucocytosis and high inflammatory markers. Evidence of ongoing clinical improvement and absence of another convincing infection signal support continued observation, with reassessment if the trajectory changes.
Extrapancreatic infection
Pneumonia, urinary infection, bloodstream infection and infected vascular devices can cause deterioration during pancreatitis. Examine and investigate these possibilities so that antimicrobial treatment and source control address the actual site.
Vascular or bowel complication
Haemorrhage, intestinal ischaemia, perforation or obstructive complications may explain acute deterioration or failure to recover. These problems can require urgent intervention even without infection of the pancreatic necrosis itself.
07ManagementImmediate care, first-line treatment, alternatives and escalation.
01Worked caseDeterioration despite active antibioticsFirst stepA constructed example shows why drainage can precede four weeks.+
- 1A 56-year-old woman develops fever and new circulatory instability on day 19 after necrotizing pancreatitis. CT shows gas in a partially encapsulated collection adjacent to the stomach, with no previous drain or visible bowel fistula. The pancreatic team treats suspected infected necrosis, obtains cultures and starts an appropriate intravenous antibiotic; she has no beta-lactam allergy and renal function is preserved.
- 2Despite initial support and Sandoz piperacillin/tazobactam 4 g/0.5 g intravenously every eight hours over 30 minutes, sepsis persists. At multidisciplinary review on day 21, imaging shows an accessible partially formed wall. The team undertakes EUS-guided drainage rather than waiting until day 28 or proceeding directly to open necrosectomy. In the following 48 hours she becomes afebrile, circulatory support is withdrawn and intake improves, supporting continuation of the step-up plan without necrosectomy.
- 3A fresh collection sample grows a susceptible enteric organism. Over the next 48 hours her temperature settles, circulatory support is withdrawn and oral intake begins to recover. The team reviews antimicrobial choice at 48–72 hours and reassesses the five-day course against source control and response; it stops treatment once the infection is judged controlled rather than extending it solely because residual necrosis remains visible.
- 4At the next specialist review she remains afebrile, renal function is stable and nutrition is improving. The drain/stent management and repeat assessment are explicitly owned by the pancreatic service. No necrosectomy is performed because drainage and medical treatment have achieved an observed response; persistent or recurrent sepsis would have reopened that decision.
02Necrosis without convincing infectionSupport and observe the actual courseUse for necrotic tissue injury in a patient without a current infection indication.+
- 1Provide organ support, analgesia and appropriate nutrition, with pancreatic-centre discussion when complications or a difficult course warrant it. Do not start antibiotics solely because CT shows a large area of necrosis or because early sterile inflammation has produced fever.
- 2EscalationReview for a new source of infection, obstruction, bleeding or another complication if progress stalls. Make monitoring and escalation triggers explicit. A stable collection can be observed while the patient improves; imaging size alone does not dictate a procedure.
- 3If prolonged sterile walled-off necrosis produces pain, luminal or biliary obstruction, nutritional failure or continuing illness, discuss intervention on its merits. The indication is the attributable clinical problem, and timing and route depend on wall maturity, location and patient condition.
03Suspected infected necrosisEscalate within a step-up strategyEscalationUse when clinical and radiological findings support infection or medical treatment is failing.+
- 1Start appropriately selected broad-spectrum intravenous antibiotics promptly, seek microbiology advice and provide nutrition and organ support. Reassess prior antimicrobial exposure, cultures and local resistance. Antifungal prophylaxis is not routine; evidence for a fungal infection or failure of treatment requires a separate assessment.
- 2If the patient is responding, defer invasive treatment where possible while the collection matures. If sepsis or organ dysfunction persists despite medical therapy, consider earlier percutaneous or endoscopic drainage when the anatomy, including partial encapsulation where relevant, permits. Haemorrhage, bowel ischaemia and perforation require urgent treatment independently of this timing preference.
- 3Choose endoscopic drainage when anatomically possible under the UK pathway; percutaneous drainage is useful when collections cannot be reached safely from the stomach or duodenum, including lateral or pelvic extensions. The approaches can complement one another. Evaluate drain position, blockage and undrained compartments if the response is poor.
- 4EscalationEscalate to endoscopic or minimally invasive surgical necrosectomy if active antibiotics and adequate drainage fail, or drainage cannot be achieved and infection remains uncontrolled. Open surgery remains an option for selected failure or another acute surgical indication. Repeat decisions should be driven by infection control, organ function and nutrition, not a predetermined number of procedures.
Key medicines and prescribing safety1 treatment · regimens, roles and cautions+
Sandoz piperacillin/tazobactam 4 g/0.5 g infusion
A UK hospital example for established infected pancreatic necrosis in an appropriate adult is 4 g piperacillin plus 0.5 g tazobactam intravenously every eight hours, infused over 30 minutes. The UHB example uses five days depending on clinical response, with a culture and clinical review at 48–72 hours; the pancreatic/microbiology team determines continuation or stopping from infection control and drainage response. For this Sandoz product, reconstitute the vial with 20 mL of a compatible solvent, such as 0.9% sodium chloride, and further dilute to an appropriate final volume of 50–150 mL, for example 100 mL. At creatinine clearance 20–40 mL/min, the suggested maximum is 4.5 g every eight hours; below 20 mL/min it is 4.5 g every 12 hours. Haemodialysis requires an additional 2.25 g after each dialysis period.Do not give with penicillin/active-substance/excipient hypersensitivity or a previous acute severe reaction to another beta-lactam; obtain a suitable alternative promptly with microbiology. No hepatic dose adjustment is specified, but renal function determines adjustment, including in older adults. The product is not recommended for ESBL-producing E. coli or K. pneumoniae bacteraemia. Review cultures, kidney function, potassium, blood counts and bleeding; concurrent vancomycin increases kidney-injury risk, methotrexate clearance can fall and anticoagulant effects require monitoring. Stop and assess severe hypersensitivity, progressive severe rash, persistent severe diarrhoea, rhabdomyolysis or suspected drug-related immune activation; established HLH requires discontinuation. Each vial contains 217 mg sodium. Prepare aseptically, use promptly and administer separately from other drugs unless compatibility is established; this formulation is incompatible with lactated Ringer’s/Hartmann’s. Pregnancy or breastfeeding use requires a clear benefit–risk decision. Review the course daily and do not prolong treatment merely for a residual sterile cavity.
08ComplicationsImportant consequences, why they occur and why they matter clinically.
Sepsis and organ failure
Infected necrosis can cause new or persistent circulatory, respiratory and renal failure. Medical treatment and source control need repeated assessment, because a patient can worsen despite an initially appropriate antimicrobial choice.
Fistula and persistent leakage
Pancreatic duct disruption or communication with adjacent bowel may produce ongoing internal or external leakage. The consequences depend on duct anatomy, drainage route, infection and nutritional loss, and may require further specialist treatment.
Nutritional and endocrine loss
Extensive injury, prolonged inadequate intake and intervention can leave exocrine or endocrine impairment. Recovery review should assess nutrition, symptoms of maldigestion and glucose control rather than ending follow-up when acute sepsis settles.
09Monitoring and follow-upTreatment response, safety checks and longer-term review.
- After starting antibiotics, record temperature, perfusion, oxygen requirement, urine output and nutritional progress. Review cultures and clinical response within 48–72 hours, sooner if the patient worsens, and narrow or change therapy when the evidence supports it.
- After drainage, document the amount and character of output, device function, pain, organ support and tolerance of nutrition. New blood, abrupt loss of drainage with deterioration or recurrent sepsis requires an urgent reassessment of the device and collection.
- Review renal function and medication toxicity during antimicrobial treatment. New fever with cytopenias, rash or other systemic findings after prolonged therapy may reflect a drug reaction as well as persistent infection; evaluate both possibilities.
- Assign a pancreatic-service plan for drain or stent review, recovery imaging when indicated and nutritional/exocrine/endocrine follow-up. Clinical resolution does not mean an indwelling device can be left without an owner or a removal decision.
10Special situationsVariants, exceptions and circumstances that change the usual approach.
Infection is a synthesis
Gas in an untreated collection is persuasive but not present in every infection. Inflammatory markers are supportive but nonspecific, and a negative aspirate can miss infection. Use concordant clinical, imaging and microbiological findings to decide, and describe remaining uncertainty honestly rather than forcing a single imperfect test to settle every case.
Delay has conditions
Demarcation and liquefaction can make intervention safer and more effective, which explains the preference to wait when possible. Deterioration despite antibiotics, limited nutrition from obstruction or an abdominal catastrophe can outweigh that benefit. The four-week point is a practical expectation for wall formation, not a prohibition on earlier necessary treatment.
Drainage can be sufficient
Successful source control does not always require removal of every fragment of dead tissue. Some patients improve with antibiotics alone; others improve after drainage without debridement. A residual radiological abnormality in a clinically recovering patient is different from persistent sepsis with an inadequately drained collection.
Anatomy determines the combination
Central collections may suit internal endoscopic drainage, whereas lateral and pelvic extensions may require percutaneous access. Combined approaches are sometimes needed. Before labelling a modality unsuccessful, assess whether its device reaches the relevant compartment and whether obstruction or remaining solid debris explains the poor response.
11Common pitfallsFrequent interpretation and management errors.
- 01
Equating pancreatic necrosis with infection and prescribing prophylactic antibiotics to an otherwise improving patient; the antimicrobial indication requires separate evidence.
- 02
Insisting on fine-needle aspiration before treating convincing infected necrosis, or using a negative aspirate as a reliable exclusion despite a deteriorating clinical course.
- 03
Waiting for four weeks despite uncontrolled sepsis or a bowel/vascular emergency; the benefit of maturation must be balanced against the harm of delay.
- 04
Moving directly to open necrosectomy without considering medical treatment, drainage feasibility and the observed response to a step-up approach.